Which Dosing Schedule Fits Your Lifestyle Better?
Wegovy vs Mounjaro Dosing: Understanding the Key Differences
When comparing Wegovy vs Mounjaro dosing schedules, the fundamental difference lies in their escalation timelines and mechanisms. Wegovy utilises a 5-step dose escalation over 16 weeks (0.25mg, 0.5mg, 1mg, 1.7mg, then 2.4mg maintenance), whilst Mounjaro follows a 4-step progression over 12 weeks. This difference reflects their distinct mechanisms: Wegovy contains semaglutide (a GLP-1 receptor agonist), whereas Mounjaro contains tirzepatide (a dual GIP and GLP-1 receptor agonist). Both require careful dose escalation to minimise potential side effects, but the extended Wegovy timeline may suit patients preferring a more gradual approach.
The practical implications of Wegovy vs Mounjaro dosing extend beyond simple scheduling. Wegovy's longer escalation period means patients spend 4 weeks at each dose level, allowing better tolerance assessment before progression. Mounjaro's faster escalation reaches therapeutic doses sooner but may require more careful monitoring. Both treatments are prescription-only medicines requiring ongoing prescriber supervision, and your clinical assessment will determine which dosing approach aligns with your individual needs and medical history.
Transparent Pricing for Wegovy vs Mounjaro Dosing Options
Understanding the cost implications of Wegovy vs Mounjaro dosing helps inform your treatment decision. Wegovy pricing at EverydayMeds starts from £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. New customers apply discount code FIRST40 at checkout to access these prices, whilst returning customers use code DOSE25. Our bundle options provide convenient multi-month supplies, such as the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99, covering your first three months of treatment.
Mounjaro pricing follows a different structure due to its distinct dosing schedule, but both treatments require similar financial planning for long-term success. The key advantage of choosing EverydayMeds for either Wegovy vs Mounjaro dosing lies in our transparent pricing with no hidden fees or subscription traps. All prices include next-day cold-chain delivery, clinical assessment processing, and ongoing prescriber support throughout your treatment journey.
Clinical Evidence Supporting Wegovy vs Mounjaro Dosing Protocols
The clinical evidence behind Wegovy vs Mounjaro dosing schedules stems from extensive trial programmes demonstrating their effectiveness. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved significant weight management outcomes, with STEP 1 showing approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo. The dose escalation protocol proved crucial for tolerability whilst maintaining efficacy.
Mounjaro's clinical programme followed different endpoints and patient populations, making direct comparison inappropriate. However, both treatments demonstrated the importance of gradual dose escalation in achieving optimal outcomes whilst minimising discontinuation due to side effects. As referenced in Wilding et al., NEJM, 2021, the systematic approach to dose escalation represents a critical component of successful GLP-1-based weight management.
How Wegovy's Mechanism Influences Dosing Requirements
Wegovy works as a GLP-1 receptor agonist, mimicking a natural fullness hormone that reduces appetite and promotes satiety after smaller meals. This mechanism requires careful dose titration because GLP-1 receptors throughout the digestive system need time to adapt to increased stimulation. The 4-week intervals in Wegovy's dosing schedule allow patients to develop tolerance to each dose level before progression. Additionally, Wegovy may help reduce food cravings by working on brain appetite centres, but this effect typically develops gradually rather than immediately. The extended escalation timeline ensures patients can differentiate between temporary adjustment effects and genuine tolerability issues.
Streamlined Ordering Process for Wegovy vs Mounjaro Dosing
Accessing either treatment through EverydayMeds follows our streamlined 3-step process designed for busy lifestyles. Complete our 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review applications within 3 working days (or 24 hours with express service), ensuring appropriate treatment selection and dosing recommendations. Once approved, your medication ships via next-day cold-chain delivery, maintaining the 2-8°C storage requirements essential for both treatments. This process applies whether you're starting Wegovy's 5-step escalation or Mounjaro's 4-step protocol, with ongoing prescriber support available throughout your treatment journey.
Storage Advantages in Wegovy vs Mounjaro Dosing Considerations
Storage practicalities represent a significant factor when comparing Wegovy vs Mounjaro dosing for real-world use. Both treatments require refrigeration at 2-8°C before first use, but Wegovy offers superior room temperature tolerance once removed from the fridge. Wegovy pens remain stable for up to 6 weeks at room temperature below 30°C, compared to Mounjaro's 21-day limit. This advantage proves particularly valuable for travel, work situations, or lifestyle flexibility. Both treatments use similar pen injection systems, but Wegovy's FlexTouch pen design includes dose escalation specifically calibrated for the 5-step progression. The extended room temperature stability makes Wegovy dosing more forgiving for patients with variable schedules or frequent travel requirements.
Personalised Approach to Wegovy vs Mounjaro Dosing Selection
Choosing between Wegovy vs Mounjaro dosing requires individual assessment of your lifestyle, medical history, and treatment preferences. Some patients prefer Wegovy's extended 16-week escalation for its gentler progression, whilst others favour Mounjaro's faster route to therapeutic doses. Your prescriber will consider factors such as previous GLP-1 experience, concurrent medications, and specific weight management goals when recommending treatment. Neither approach is inherently superior - the optimal choice depends on personal circumstances and clinical factors.
EverydayMeds supports both pathways with identical service standards and ongoing clinical oversight. Our prescribers can adjust dosing schedules within licensed parameters if you experience tolerability issues or require modified escalation timing. This personalised approach ensures your chosen treatment - whether Wegovy or Mounjaro - integrates effectively with your lifestyle and maximises your chances of long-term success.
Secure Your Wegovy vs Mounjaro Dosing Decision Today
Ready to begin your weight management journey with professional support and transparent pricing? Both Wegovy and Mounjaro are available through our secure online platform with discount codes FIRST40 (new customers) or DOSE25 (returning customers) applied at checkout. Start with our comprehensive clinical assessment to determine which dosing approach suits your needs, backed by our GPhC-registered pharmacy credentials (#9012878) and next-day delivery commitment. Our clinical team provides ongoing support throughout your treatment, whether you choose Wegovy's 5-step escalation or Mounjaro's alternative protocol. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment and join thousands of patients already benefiting from our professional weight management support. Both Wegovy and Mounjaro are available from EverydayMeds - your prescriber can help determine which is right for you.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
